SNN vs. GILD
Compare and contrast key facts about Smith & Nephew plc (SNN) and Gilead Sciences, Inc. (GILD).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SNN or GILD.
Correlation
The correlation between SNN and GILD is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
SNN vs. GILD - Performance Comparison
Key characteristics
SNN:
0.58
GILD:
2.16
SNN:
0.95
GILD:
2.92
SNN:
1.15
GILD:
1.37
SNN:
0.35
GILD:
1.80
SNN:
1.34
GILD:
10.39
SNN:
12.40%
GILD:
5.16%
SNN:
27.76%
GILD:
25.94%
SNN:
-55.20%
GILD:
-70.82%
SNN:
-36.71%
GILD:
-16.88%
Fundamentals
SNN:
$12.57B
GILD:
$128.00B
SNN:
$0.94
GILD:
$4.76
SNN:
30.45
GILD:
21.60
SNN:
0.95
GILD:
0.22
SNN:
2.16
GILD:
4.45
SNN:
2.38
GILD:
6.77
SNN:
$5.81B
GILD:
$28.73B
SNN:
$4.05B
GILD:
$23.07B
SNN:
$1.24B
GILD:
$9.89B
Returns By Period
In the year-to-date period, SNN achieves a 17.20% return, which is significantly higher than GILD's 5.65% return. Over the past 10 years, SNN has underperformed GILD with an annualized return of 0.08%, while GILD has yielded a comparatively higher 2.62% annualized return.
SNN
17.20%
9.63%
18.60%
16.07%
-4.54%
0.08%
GILD
5.65%
-7.92%
1.91%
55.70%
8.91%
2.62%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SNN vs. GILD — Risk-Adjusted Performance Rank
SNN
GILD
SNN vs. GILD - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Smith & Nephew plc (SNN) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SNN vs. GILD - Dividend Comparison
SNN's dividend yield for the trailing twelve months is around 2.65%, less than GILD's 3.20% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SNN Smith & Nephew plc | 2.65% | 3.05% | 2.75% | 2.79% | 2.17% | 1.78% | 1.51% | 1.96% | 1.76% | 2.08% | 1.71% | 1.52% |
GILD Gilead Sciences, Inc. | 3.20% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% | 0.00% |
Drawdowns
SNN vs. GILD - Drawdown Comparison
The maximum SNN drawdown since its inception was -55.20%, smaller than the maximum GILD drawdown of -70.82%. Use the drawdown chart below to compare losses from any high point for SNN and GILD. For additional features, visit the drawdowns tool.
Volatility
SNN vs. GILD - Volatility Comparison
The current volatility for Smith & Nephew plc (SNN) is 7.23%, while Gilead Sciences, Inc. (GILD) has a volatility of 9.75%. This indicates that SNN experiences smaller price fluctuations and is considered to be less risky than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SNN vs. GILD - Financials Comparison
This section allows you to compare key financial metrics between Smith & Nephew plc and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SNN vs. GILD - Profitability Comparison
SNN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Smith & Nephew plc reported a gross profit of 2.07B and revenue of 2.98B. Therefore, the gross margin over that period was 69.5%.
GILD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Gilead Sciences, Inc. reported a gross profit of 5.71B and revenue of 6.67B. Therefore, the gross margin over that period was 85.6%.
SNN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Smith & Nephew plc reported an operating income of 329.00M and revenue of 2.98B, resulting in an operating margin of 11.0%.
GILD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Gilead Sciences, Inc. reported an operating income of 3.15B and revenue of 6.67B, resulting in an operating margin of 47.2%.
SNN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Smith & Nephew plc reported a net income of 198.00M and revenue of 2.98B, resulting in a net margin of 6.6%.
GILD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Gilead Sciences, Inc. reported a net income of 1.32B and revenue of 6.67B, resulting in a net margin of 19.7%.